Fiona A. Chapman

958 total citations
16 papers, 318 citations indexed

About

Fiona A. Chapman is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fiona A. Chapman has authored 16 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fiona A. Chapman's work include Apelin-related biomedical research (6 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Fiona A. Chapman is often cited by papers focused on Apelin-related biomedical research (6 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Fiona A. Chapman collaborates with scholars based in United Kingdom, Switzerland and Sweden. Fiona A. Chapman's co-authors include Neeraj Dhaun, David E. Newby, Janet J. Maguire, Anthony P. Davenport, Patrick B. Mark, Alan G. Jardine, Duuamene Nyimanu, Jennifer S. Lees, Miles D. Witham and Dan Pugh and has published in prestigious journals such as The Lancet, Nature Communications and Cardiovascular Research.

In The Last Decade

Fiona A. Chapman

14 papers receiving 314 citations

Peers

Fiona A. Chapman

PHARM

SURGE

EDM

CCM

Dong-Rui Chen China

Piotr Koźmiński Poland

Beata Marie Redublo Quinto Brazil

Víctor Barrientos Chile

Toru Kagawa Japan

Jianzhong Xu China

Kaspar Tootsi Estonia

Aditya Goud United States

Nakhoul Nakhoul Israel

Ze-Bei Zhang China

Dong-Rui Chen China

Fiona A. Chapman

38 ×0.3

PHARM

63 ×0.7

SURGE

66 ×1.1

EDM

47 ×0.8

122 ×2.5

CCM

Citations per year, relative to Fiona A. Chapman Fiona A. Chapman (= 1×) peers Dong-Rui Chen

Countries citing papers authored by Fiona A. Chapman

Since Specialization

Citations

This map shows the geographic impact of Fiona A. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona A. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona A. Chapman more than expected).

Fields of papers citing papers by Fiona A. Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona A. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona A. Chapman. The network helps show where Fiona A. Chapman may publish in the future.

Co-authorship network of co-authors of Fiona A. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona A. Chapman. A scholar is included among the top collaborators of Fiona A. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona A. Chapman. Fiona A. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Salehi, Tania, Gavin Chapman, Tariq E. Farrah, et al.. (2025). Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis. Kidney International Reports. 10(7). 2334–2343.

Chapman, Fiona A., Vanessa Melville, Janet J. Maguire, et al.. (2024). Cardiovascular and renal effects of apelin in chronic kidney disease: a randomised, double-blind, placebo-controlled, crossover study. Nature Communications. 15(1). 8387–8387. 6 indexed citations

Chapman, Fiona A., et al.. (2024). Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests. European Journal of Endocrinology. 191(5). 491–498.

Chapman, Fiona A., et al.. (2024). Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin. Journal of the Endocrine Society. 8(7). bvae106–bvae106. 3 indexed citations

Farrah, Tariq E., Dan Pugh, Fiona A. Chapman, et al.. (2023). Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment. Nature Communications. 14(1). 7720–7720. 16 indexed citations

Chapman, Fiona A., Janet J. Maguire, David E. Newby, Anthony P. Davenport, & Neeraj Dhaun. (2023). Targeting the apelin system for the treatment of cardiovascular diseases. Cardiovascular Research. 119(17). 2683–2696. 44 indexed citations

Nyimanu, Duuamene, Fiona A. Chapman, Peter J. Gallacher, et al.. (2022). Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function. British Journal of Clinical Pharmacology. 88(12). 5295–5306. 14 indexed citations

Dospinescu, Paula, Nick Fluck, Dana Kidder, et al.. (2021). A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis. Rheumatology International. 41(10). 1811–1814. 7 indexed citations

Chapman, Fiona A., Duuamene Nyimanu, Janet J. Maguire, et al.. (2021). The therapeutic potential of apelin in kidney disease. Nature Reviews Nephrology. 17(12). 840–853. 75 indexed citations

10.

Chapman, Fiona A., et al.. (2021). Hypertension: Current trends and future perspectives. British Journal of Clinical Pharmacology. 87(10). 3721–3736. 35 indexed citations

11.

Chapman, Gavin, Tariq E. Farrah, Fiona A. Chapman, et al.. (2021). Utility of interval kidney biopsy in ANCA-associated vasculitis. Lara D. Veeken. 61(5). 1966–1974. 13 indexed citations

12.

Chapman, Fiona A., Jonathan E. Dickerson, Conal Daly, Marc Clancy, & Colin Geddes. (2019). Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant. Annals of Transplantation. 24. 625–630. 4 indexed citations

13.

Stapleton, Caragh P., Kelly A. Birdwell, Amy Jayne McKnight, et al.. (2018). Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort. American Journal of Transplantation. 19(3). 801–810. 27 indexed citations

14.

Lees, Jennifer S., Fiona A. Chapman, Miles D. Witham, Alan G. Jardine, & Patrick B. Mark. (2018). Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis. Heart. 105(12). 938–945. 65 indexed citations

15.

Blackmur, James P., Fiona A. Chapman, Christopher Bellamy, et al.. (2013). Anti-TNF- therapy for renal amyloid as a complication of Crohn's disease. QJM. 107(1). 57–59. 7 indexed citations

16.

Chapman, Fiona A., James P. Blackmur, James Fotheringham, et al.. (2012). An uncommon cause of pleural effusions in a dialysis patient. The Lancet. 380(9837). 186–186. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact